Crossmark

Attitudes and barriers to participation in window-of-opportunity trials reported by White and Asian/Asian British ethnicity patients who have undergone treatment for endometrial cancer

Crossref DOI link: https://doi.org/10.1186/s13063-023-07572-x

Published Online: 2023-11-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mandane, B.

Amirthanayagam, A.

Patel, N.

Darko, N.

Moss, E. L. https://orcid.org/0000-0002-2650-0172
License Information

Text and Data Mining valid from 2023-11-25

Version of Record valid from 2023-11-25
More Information

Article History

Received: 15 June 2022

Accepted: 4 August 2023

First Online: 25 November 2023

Declarations

:

: Ethical approval for the study was granted by the North-West Liverpool East Research Ethics Committee (18/NW/0788), and informed consent was obtained from all study participants.

: Informed consent was obtained from all study participants for publication.

: EM has served on advisory boards for Inivata and GlaxoSmithKline; received speaker fees from GlaxoSmithKline; and has received research grants from Intuitive Surgical, British Gynaecological Cancer Society and Hope Against Cancer for unrelated work.

Document is current

Any future updates will be listed below